Game-Changing Updates in the Management of Sickle Cell Disease

game s11

Featured

Game-Changing Updates in the Management of Sickle Cell Disease

The speakers and panelists discuss sickle cell disease, its prevalence, new gene therapy management strategies, and relevant ethical considerations. A pioneering CRISPR patient gives her perspective on undergoing gene-editing therapy and how that has impacted her health and quality of life.

CME & Ethics credit available